Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
17.22
+0.16 (0.94%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Bausch + Lomb Revenue
In the year 2025, Bausch + Lomb had annual revenue of $5.10B with 6.47% growth. Bausch + Lomb had revenue of $1.41B in the quarter ending December 31, 2025, with 9.77% growth.
Revenue (ttm)
$5.10B
Revenue Growth
+6.47%
P/S Ratio
1.18
Revenue / Employee
$392,385
Employees
13,000
Market Cap
6.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.24B |
| Avantor | 6.55B |
| AptarGroup | 3.78B |
| Minimed Group | 2.89B |
| Envista Holdings | 2.72B |
| ICU Medical | 2.23B |
| Teleflex | 1.99B |
| Merit Medical Systems | 1.52B |
BLCO News
- 8 hours ago - Bausch + Lomb Launches R&D “Teach-in” Webinar Series - Business Wire
- 13 days ago - Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY® - Business Wire
- 19 days ago - Bausch + Lomb Corporation (BLCO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance - Business Wire
- 6 weeks ago - Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18 - Business Wire
- 7 weeks ago - Bausch + Lomb Corporation (BLCO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. - Business Wire
- 2 months ago - Bausch + Lomb Completes Refinancing of Outstanding Term B Loans - Business Wire